The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

Sen, Sedat; Tuncer, Asli; Ozakbas, Serkan; Uzunkopru, Cihat; Baba, Cavid; Demir, Serkan; Beckmann, Yesim; Gumus, Haluk; Arslan, Gokhan; Kilic, Ahmet; Altintas, Ayse; Yuceyar, Nur; Turan, Omer; Tutuncu, Melih; Terzi, Murat; Acar, Pinar; Bunul, Sena; Balci, Belgin; Bir, Levent; Koseoglu, Mesrure; Mungan, Semra; Gunduz, Tuncay; Dogan, Ipek; Kotan, Dilcan; Uygunoglu, Ugur; Ekmekci, Ozgul; Demirkiran, DURUHAN; Kamisli, Ozden; Kabay, Sibel; Tamam, Yusuf; Omerhoca, Sami; Sevim, Serhan; Guler, Sibel; Kurtuncu, Murat; Efendi, Husnu; Karabudak, Rana; Siva, Aksel

doi:10.1016/j.msard.2021.103399

The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

Copy For Citation

Sen S., Tuncer A., Ozakbas S., Uzunkopru C., Baba C., Demir S., ...More

Multiple Sclerosis and Related Disorders, vol.58, pp.103399, 2022 (SCI-Expanded)

Publication Type: Article / Article
Volume: 58
Publication Date: 2022
Doi Number: 10.1016/j.msard.2021.103399
Journal Name: Multiple Sclerosis and Related Disorders
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
Page Numbers: pp.103399
Keywords: Neuromyelitis optica spectrum disorders, Myelin oligodendrocyte glycoprotein antibody-associated disorders, Disease modifying treatment, Coronavirus, SARS-CoV-2
Çukurova University Affiliated: Yes

Abstract

Background: COVID-19 is a multisystemic infection with variables consequences depending on individual and comorbid conditions. The course and outcomes of COVID-19 during neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are not clearly known.